These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 377553)

  • 1. Chemotherapy for advanced soft-tissue sarcomas: results of phase I and II cooperative studies.
    Mitts DL; Gerhardt H; Armstrong D; Aust JB; Cruz AB
    Tex Med; 1979 May; 75(5):43-7. PubMed ID: 377553
    [No Abstract]   [Full Text] [Related]  

  • 2. Current perspectives in the management of soft-tissue sarcoma. The role of chemotherapy in multimodality therapy.
    Bramwell VH
    Can J Surg; 1988 Nov; 31(6):390-6. PubMed ID: 3052763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic.
    Demetri GD; Elias AD
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):765-85. PubMed ID: 7490240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of modalities in soft tissue sarcomas.
    Karakousis CP
    Int Adv Surg Oncol; 1982; 5():91-113. PubMed ID: 6896509
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas.
    Maurel J; López-Pousa A; de Las Peñas R; Fra J; Martín J; Cruz J; Casado A; Poveda A; Martínez-Trufero J; Balañá C; Gómez MA; Cubedo R; Gallego O; Rubio-Viqueira B; Rubió J; Andrés R; Sevilla I; de la Cruz JJ; Del Muro XG; Buesa JM
    J Clin Oncol; 2009 Apr; 27(11):1893-8. PubMed ID: 19273704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy and immuno-chemotherapy in malignant lymphoma].
    Nishikori M; Nasu K; Shirakawa S; Karitani Y
    Rinsho Ketsueki; 1983 Apr; 24(4):320-9. PubMed ID: 6350639
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of combined chemotherapy of malignant lymphoma at the hematological department of the clinical hospital in Belgrade].
    Plécas V; Dragović M; Vidaković B; Jelić S; Obradović M
    Srp Arh Celok Lek; 1976 Sep; 104(9):645-52. PubMed ID: 800287
    [No Abstract]   [Full Text] [Related]  

  • 8. Effectiveness of chemotherapy in non-rhabdomyosarcoma soft tissue sarcomas.
    Ferrari A; Collini P
    Pediatr Blood Cancer; 2005 Aug; 45(2):226-7; author reply 228. PubMed ID: 15782404
    [No Abstract]   [Full Text] [Related]  

  • 9. Results of the Royal Marsden Hospital second soft tissue sarcoma schedule (STS II) chemotherapy regimen in the management of advanced sarcoma.
    Bryant BM; Wiltshaw E
    Cancer Treat Rep; 1980; 64(4-5):689-92. PubMed ID: 7000348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of chemotherapy in the treatment of soft tissue sarcoma in adults].
    Bui NB; Coindre JM; Chauvergne J; Maree D; Denepoux R; Mage P
    J Chir (Paris); 1986 Jan; 123(1):53-8. PubMed ID: 3514642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas.
    Yap BS; Baker LH; Sinkovics JG; Rivkin SE; Bottomley R; Thigpen T; Burgess MA; Benjamin RS; Bodey GP
    Cancer Treat Rep; 1980 Jan; 64(1):93-8. PubMed ID: 7379060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy for soft tissue sarcomas.
    Bramwell VH
    Cancer Treat Res; 1989; 44():93-102. PubMed ID: 2577164
    [No Abstract]   [Full Text] [Related]  

  • 13. Chlorozotocin: phase II evaluation in patients with advanced sarcomas.
    Sordillo PP; Magill GB; Gralla RJ
    Cancer Treat Rep; 1981; 65(5-6):513-4. PubMed ID: 6453647
    [No Abstract]   [Full Text] [Related]  

  • 14. [Palliative chemotherapy of adult soft tissue sarcomas with an association of cyclophosphamide-vincristine-adriamycine-dacarbazine (CYVADIC) (author's transl)].
    Bui B; Chauvergne J; Durand M; Brunet R
    Bull Cancer; 1981; 68(1):1-5. PubMed ID: 7225604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy in adult soft tissue sarcoma.
    Jain A; Sajeevan KV; Babu KG; Lakshmaiah KC
    Indian J Cancer; 2009; 46(4):274-87. PubMed ID: 19749457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of adjuvant chemotherapy in the management of patients with soft tissue sarcomas.
    Edmonson JH
    Cancer Treat Rep; 1984 Sep; 68(9):1063-6. PubMed ID: 6383603
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination chemotherapy with DTIC (NSC-45388) in advanced malignant melanoma, soft tissue sarcomas, and Hodgkin's disease.
    Beretta G; Bonadonna G; Bajetta E; Tancini G; De Lena M; Azzarelli A; Veronesi U
    Cancer Treat Rep; 1976 Feb; 60(2):205-11. PubMed ID: 769975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study in advanced sarcoma: randomized trial of pyrazofurin versus combination cyclophosphamide, doxorubicin, and cis-dichlorodiammineplatinum(II) (CAP).
    Cormier WJ; Hahn RG; Edmonson JH; Eagan RT
    Cancer Treat Rep; 1980; 64(4-5):655-8. PubMed ID: 7191779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathology and potential therapeutic targets in soft-tissue sarcoma.
    Todd R; Lunec J
    Expert Rev Anticancer Ther; 2008 Jun; 8(6):939-48. PubMed ID: 18533803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic adjuvant chemotherapy for soft tissue sarcomas.
    Zalupski MM; Baker LH
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):787-800. PubMed ID: 7490241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.